Speaker illustration

Doctor Masaharu Akao

Kyoto Medical Center, National Hospital Organization, Kyoto (Japan)

Member of:

European Society of Cardiology

Balancing stroke and bleeding risks in Asian patients with atrial fibrillation.

Event: ESC CONGRESS 2020 - The Digital Experience

Topic: Stroke

Session: Racial and Cultural Differences in anti-Thrombotic Therapy between Europe and Asia

Thumbnail

Impact of creatinine clearance on clinical outcomes in elderly atrial fibrillation patients receiving apixaban: J-ELD AF Registry sub-analysis

Event: ESC CONGRESS 2020 - The Digital Experience

Topic: Oral Anticoagulation

Session: Atrial Fibrillation ePosters

Thumbnail

Left atrial enlargement as an independent risk factor for ischemic stroke in Japanese atrial fibrillation patients: pooled analysis of five major Japanese atrial fibrillation registries

Event: ESC CONGRESS 2019

Topic: Stroke Prevention

Session: Epidemiology of atrial fibrillation

Thumbnail

Case 2: an atrial fibrillation patient with high CHA2DS2-VASc Score, a gastrointestinal bleed and renal impairment

Event: ESC Congress 2018

Topic: Atrial Fibrillation (AF)

Session: Atrial fibrillation: from Guidelines to clinical practice

Thumbnail

Temporal change of anticoagulation therapy and its outcomes of Japanese atrial fibrillation patients in the real-world clinical practice: the Fushimi AF Registry.

Event: ESC CONGRESS 2016

Topic: Atrial fibrillation (AF)

Session: Antithrombotic therapy in atrial fibrillation 2

Thumbnail

This platform is supported by

logo Novo Nordisk